Zero Candida Technologies (TSXV:ZCT) ROE % Adjusted to Book Value: -27.71% (As of Dec. 2025)


TSXV:ZCT Zero Candida Technologies Inc TSXV:ZCT
14 GF Score
Price C$0.16
! 1 Warning Sign
View Full Analysis

What is Zero Candida Technologies ROE % Adjusted to Book Value?

Zero Candida Technologies TSXV:ZCT 14 ROE % Adjusted to Book Value is -27.71% as of Dec. 2025. GuruFocus rates TSXV:ZCT with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Zero Candida Technologies's ROE % for the quarter that ended in Dec. 2025 was -68.16%. Zero Candida Technologies's PB Ratio for the quarter that ended in Dec. 2025 was 2.46. Zero Candida Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -27.71%.

Zero Candida Technologies ROE % Adjusted to Book Value Related Terms

Zero Candida Technologies ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Zero Candida Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zero Candida Technologies ROE % Adjusted to Book Value Chart

Zero Candida Technologies Annual Data
Trend Jul23 Jul24 Dec25
ROE % Adjusted to Book Value
0.00 0.00 -61.44

Zero Candida Technologies Quarterly Data
Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -13.76 -25.46 -15.06 -27.71

TSXV:ZCT vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, Zero Candida Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zero Candida Technologies ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zero Candida Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zero Candida Technologies's ROE % Adjusted to Book Value falls into.


TSXV:ZCT
14GF Score
Zero Candida Technologies Inc TSXV:ZCT
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zero Candida Technologies ROE % Adjusted to Book Value Calculation

Zero Candida Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-151.14% / 2.46
=-61.44%

Zero Candida Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-68.16% / 2.46
=-27.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -27.71% mean?
Zero Candida Technologies (TSXV:ZCT) has a ROE % Adjusted to Book Value of -27.71% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Zero Candida Technologies and its competitors.
Is Zero Candida Technologies' ROE % Adjusted to Book Value too high?
Zero Candida Technologies' current ROE % Adjusted to Book Value is -27.71%. Overall, Zero Candida Technologies has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zero Candida Technologies' ROE % Adjusted to Book Value compare to ABT and SYK?
Zero Candida Technologies' ROE % Adjusted to Book Value of -27.71% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Zero Candida Technologies and its competitors. Zero Candida Technologies's current ROE % Adjusted to Book Value is -27.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zero Candida Technologies stock overvalued right now?
Zero Candida Technologies (TSXV:ZCT) has a current ROE % Adjusted to Book Value of -27.71%. The current ROE % Adjusted to Book Value is -27.71%. Zero Candida Technologies' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Zero Candida Technologies (TSXV:ZCT), the current ROE % Adjusted to Book Value is -27.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zero Candida Technologies Business Description

Address 666 Burrard Street, Suite 500, Vancouver, BC, CAN, V6C 3P6
Zero Candida Technologies Inc is engaged in providing female healthcare solutions. The company technology uses a controlled Blue Light to destroy the fungus at record speed and without side effects. It focused on developing and commercializing several patents and patent applications concerning an AI smart tampon-like device, designed to treat Candidiasis and transfer medical information via Wi-Fi to the doctor.
14GF Score

Get the complete analysis for TSXV:ZCT

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.16
Price